Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Oxycodon und Naloxon, ATC N02AA55

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 594 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Oxycodon und Naloxon, ATC N02AA55

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

50 / 100

Complexity

30 / 100

Risk factors

Automatic termination if a subsequent nationwide or regional rebate contract is concluded for the same active substance...

No estimated contract value disclosed; potential low volume or uncertain revenue.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Supply of pharmaceutical products containing Oxycodon and Naloxon (ATC N02AA55)
  • Entering into non-exclusive rebate agreements with AOK Bayern
Show full summary

Open-house model for non-exclusive pharmaceutical rebate agreements for Oxycodon and Naloxon (ATC N02AA55) with AOK Bayern. All interested pharmaceutical companies meeting eligibility can sign identical, non-negotiable contracts from June 1, 2026 to May 31, 2028. No competitive selection; any eligible company can join at any time until April 3, 2028. Estimated value not provided.

Risks

Automatic termination if a subsequent nationwide or regional rebate contract is concluded for the same active substance...

No estimated contract value disclosed; potential low volume or uncertain revenue.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only pharmaceutical companies are eligible as potential partners

Administrative

  • Contract must be signed with qualified electronic signature or submitted in paper form with handwritten signature
  • Declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; all eligible participants are accepted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Oxycodon und Naloxon, ATC N02AA55

Non-exclusive rebate agreements for active substances Oxycodon and Naloxon (ATC N02AA55). All eligible pharmaceutical companies can participate. Contracts run from June 1, 2026 to May 31, 2028. Submission via communication area on www.dtvp.de.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

May 2026 - May 2028

Category

Pharmaceutical products

Award Criteria

No award criteria specified; all eligible participants are accepted.

Deadline

Deadline Apr 03, 2028

Procurement Details

Publication date
14 Apr 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
255858-2026

Documents (2)

Similar tenders